Navigation Links
Lilly, Covance Strategic Alliance Proves Win-Win For Both Companies, Patients
Date:2/26/2010

at Lilly and Covance for helping patients is evident," remarked Andrew Dahlem, Ph.D, vice president Lilly Research Laboratories (LRL) Operations/ LRL Europe. "With the Lilly/Covance model, everyone on the team understands the end goal and their role in it, and because of this, has a greater sense of urgency and personal pride in advancing the molecule to the next stage."

Covance will continue to invest in its Greenfield site, in order to grow it into a world-class research organization that could service the drug development needs of all pharmaceutical and biotechnology companies.

"This strategic alliance has proven it's a win for Lilly in terms of advancing of pipeline, in terms of job opportunities for Lilly employees and for the state of Indiana, with Covance continuing to grow its business.  I also see it as a win for patients – those who will benefit from new and better treatments achieved from the speed this alliance is generating and through the cost reductions Lilly is achieving," said Bart Peterson, Lilly senior vice president corporate affairs and communications.

Lilly and Covance entered into a long-term strategic alliance in August 2008, in which Covance acquired L
'/>"/>

SOURCE Covance Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
2. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
3. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
4. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
5. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
6. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
7. Covance Decides to Pursue Its Original Preclinical Strategy in China
8. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
9. Covance Purchases Equity Stake in Caprion Proteomics
10. Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
11. Jina Ventures Advises Swiss Pharma Contract on Strategic Sale to Covance Inc
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2014)... Tampa, FL (Aug. 18, 2014) -- A new ... South Florida (USF) Morsani College of Medicine and ... the life-threatening complications of interventional cardiovascular disease treatment. ... model that the novel molecular therapy could selectively ... healing following a medical procedure using a balloon ...
(Date:8/18/2014)... Aug. 18, 2014 BioElectronics Corporation ... consumer medical devices said that its EVP ... by CEOLIVE.TV as part of its Executive ... is available at http://ceolive.tv/bioelectronics-corp-otc-biel/biel-videos/2282-ceolive-tv-interview-bioelectronics-corp-otcqb-biel ... to investors the unique advantages of BioElectronics ...
(Date:8/18/2014)... efficiency and data storage may someday run ... polarizations to read and write digital information, ... technology. But ferroelectrics must first overcome a ... habit of "forgetting" stored data. , ... Energy,s Brookhaven National Laboratory have discovered nanoscale ...
(Date:8/18/2014)... August 18, 2014 According ... Market Research "Life Science Reagents Market(Products- PCR Reagent ... Chromatography, In-Vitro Diagnostic Reagents and Others; End Users- ... Clinical Laboratories, and Forensic Laboratories)- Global Industry Analysis, ... 2019", the global life science reagents market was ...
Breaking Biology Technology:Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 2BioElectronics EVP Dr. Deepak Kotak Interviewed on CEO Live 3Promising ferroelectric materials suffer from unexpected electric polarizations 2Promising ferroelectric materials suffer from unexpected electric polarizations 3Promising ferroelectric materials suffer from unexpected electric polarizations 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 2Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 3Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 4Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research 5
... - ARIUS Research Inc., (TSX:,ARI), a biotechnology company ... today announced that David Young, MD, President and,Chief ... Chinese Global,Financial Forum. Dr. Young will present on ... available prior to and following his presentation at ...
... DuPont Chairman and,CEO Charles O. Holliday, Jr., today told ... the world to keep pace with the rapid,growth in ... "Biotechnology is the most powerful tool available to secure ... holds the promise,to deliver the world more, higher quality ...
... Angiotech Pharmaceuticals,Inc. (NASDAQ: ANPI , TSX: ... company, today announced preliminary financial results from,the ... updated its financial,outlook for the full year ... the,release of Boston Scientific Corporation,s (BSC) third ...
Cached Biology Technology:ARIUS to present at Chinese Global Financial Forum 2Biotechnology Needed to Help Meet Growing Global Needs for Food, Feed, Fuel and Materials, DuPont Chairman & CEO Says at World Food Prize 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 2Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 3Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 4Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 5Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 6Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 7Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 8Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 9Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 10Angiotech announces preliminary third quarter financial results and updates fiscal 2007 outlook 11
(Date:8/20/2014)... -- Bay Area Lyme Foundation, which aims to make ... applauds new research published in an upcoming issue of ... Diseases . The findings show that ticks that ... the year, making the threat of Lyme disease year-round. ... of Public Health (CDPH) Vector-borne Disease Section and University ...
(Date:8/20/2014)... who have suffered concussions ready to return to action? ... high school athletes who head back on the field ... regression in their abilities to simultaneously walk and do ... changes in their balance and/or altered walking speed, was ... 12 had returned to activity in less than a ...
(Date:8/20/2014)... Virginia Tech,s Wu Feng has built upon a National ... in the Cloud" program, and synergistically complemented it with ... the Air Force on "big computing" for mini-drones and ... Institutes of Health on "big data" for the life ... aspects from each grant, he was able to tell ...
Breaking Biology News(10 mins):Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3Recovery reversal seen in Oregon study of returning concussed athletes 2Recovery reversal seen in Oregon study of returning concussed athletes 3The internet was delivered to the masses; parallel computing is not far behind 2The internet was delivered to the masses; parallel computing is not far behind 3The internet was delivered to the masses; parallel computing is not far behind 4
... Virtually all babies in the U.S. have their heels ... for genetic testing. These "heel stick" tests identify rare ... more disorders are added to the screening ?many states ... on the rise. In the June issue of Pediatrics, ...
... of their parents may give birds a preference for ... more exactly match those of their parents. Such learned ... traits and strong morphological differences between sexes ?phenomena seen ... reported by Carel ten Cate, Machteld Verzijden and Eric ...
... sub-Saharan Africa, according to the World Health Organization, and ... achieved limited success. But what if a vaccine against ... of Africa ?chancroid ?was relatively easy to develop and ... , That may be the case, according to researchers ...
Cached Biology News:Newborn screening can cause unnecessary parental stress 2Newborn screening can cause unnecessary parental stress 3Zebra finch males prefer females with exaggerated maternal traits 2Vaccine shown effective against chancroid 2Vaccine shown effective against chancroid 3
Hepatocyte Differentiation Environment...
High voltage electrophoresis power supply...
Mouse monoclonal antibody to ANAPC2 - anaphase promoting complex subunit 2...
... Drummond Scientific has a long and ... microinjection apparatus. Several years ago we ... displacement microdispenser was being modified to ... unit by redesigning the microdispenser to ...
Biology Products: